SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS

Identification of risk factors associated with presence of atrial fibrillation (AF) in patients with aortic valve stenosis (AS) remains to be unraveled.The aim of the study was to investigate relationship between profibrotic biomarkers and presence of AF in AS patientsMethods. 191 patients (29,8% ma...

Full description

Bibliographic Details
Main Authors: T A Tipteva, O S Chumakova, N E Reznichenko, V I Safaryan, T N Baklanova, N M Voloshina, D A Zateyshchikov
Format: Article
Language:English
Published: Eco-vector 2017-06-01
Series:Клиническая практика
Subjects:
Online Access:https://journals.eco-vector.com/clinpractice/article/viewFile/8070/6492
_version_ 1797720109878345728
author T A Tipteva
O S Chumakova
N E Reznichenko
V I Safaryan
T N Baklanova
N M Voloshina
D A Zateyshchikov
author_facet T A Tipteva
O S Chumakova
N E Reznichenko
V I Safaryan
T N Baklanova
N M Voloshina
D A Zateyshchikov
author_sort T A Tipteva
collection DOAJ
description Identification of risk factors associated with presence of atrial fibrillation (AF) in patients with aortic valve stenosis (AS) remains to be unraveled.The aim of the study was to investigate relationship between profibrotic biomarkers and presence of AF in AS patientsMethods. 191 patients (29,8% male, 77,7±0,59 years) with AS (defined as aortic valve area (AVA) ≤ 2,0 sm2) were enrolled in the study. Clinical, echocardiographic and biochemical variables, including serum TGFβ1 and osteopontin levels were compared between 2 groups of patients: with and without AF. Results. 83(36,5%) of AS patients had AF. In logistic regression models independent associations between AVA index (p=0,040), left atrial volume (p=0,021), OPN (р=0,009) and presence of AF were found. Patients with serum OPN level 10,05 ng/ml had twice more higher AF incidence comparedto patients with serum OPN level ≤ 10,05 ng/ml (53,8% and 29,2%, respectively, p=0,020).Conclusion. Serum OPN level was independently associated with presence of AF in AS patients, thus we speculate on it’s predominant profibrotic role in the left atrium.
first_indexed 2024-03-12T09:15:45Z
format Article
id doaj.art-381894724c904f1d82ea09a3ee7a92e2
institution Directory Open Access Journal
issn 2220-3095
2618-8627
language English
last_indexed 2024-03-12T09:15:45Z
publishDate 2017-06-01
publisher Eco-vector
record_format Article
series Клиническая практика
spelling doaj.art-381894724c904f1d82ea09a3ee7a92e22023-09-02T14:50:25ZengEco-vectorКлиническая практика2220-30952618-86272017-06-018231310.17816/clinpract823-137516SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIST A TiptevaO S ChumakovaN E ReznichenkoV I SafaryanT N BaklanovaN M VoloshinaD A ZateyshchikovIdentification of risk factors associated with presence of atrial fibrillation (AF) in patients with aortic valve stenosis (AS) remains to be unraveled.The aim of the study was to investigate relationship between profibrotic biomarkers and presence of AF in AS patientsMethods. 191 patients (29,8% male, 77,7±0,59 years) with AS (defined as aortic valve area (AVA) ≤ 2,0 sm2) were enrolled in the study. Clinical, echocardiographic and biochemical variables, including serum TGFβ1 and osteopontin levels were compared between 2 groups of patients: with and without AF. Results. 83(36,5%) of AS patients had AF. In logistic regression models independent associations between AVA index (p=0,040), left atrial volume (p=0,021), OPN (р=0,009) and presence of AF were found. Patients with serum OPN level 10,05 ng/ml had twice more higher AF incidence comparedto patients with serum OPN level ≤ 10,05 ng/ml (53,8% and 29,2%, respectively, p=0,020).Conclusion. Serum OPN level was independently associated with presence of AF in AS patients, thus we speculate on it’s predominant profibrotic role in the left atrium.https://journals.eco-vector.com/clinpractice/article/viewFile/8070/6492tgfβ1aortic stenosisatrial fibrillation, osteopontintgfβ1fibrosis
spellingShingle T A Tipteva
O S Chumakova
N E Reznichenko
V I Safaryan
T N Baklanova
N M Voloshina
D A Zateyshchikov
SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS
Клиническая практика
tgfβ1
aortic stenosis
atrial fibrillation, osteopontin
tgfβ1
fibrosis
title SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS
title_full SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS
title_fullStr SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS
title_full_unstemmed SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS
title_short SERUM OSTEOPONTIN LEVEL IS ASSOCIATED WITH PRESENCE OF ATRIAL FIBRILLATION IN CALCIFIC AORTIC VALVE STENOSIS
title_sort serum osteopontin level is associated with presence of atrial fibrillation in calcific aortic valve stenosis
topic tgfβ1
aortic stenosis
atrial fibrillation, osteopontin
tgfβ1
fibrosis
url https://journals.eco-vector.com/clinpractice/article/viewFile/8070/6492
work_keys_str_mv AT tatipteva serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis
AT oschumakova serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis
AT nereznichenko serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis
AT visafaryan serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis
AT tnbaklanova serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis
AT nmvoloshina serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis
AT dazateyshchikov serumosteopontinlevelisassociatedwithpresenceofatrialfibrillationincalcificaorticvalvestenosis